Clinical Trials on Squamous Cell Carcinoma of Unknown Primary Origin in Belgium
Total 248 results
-
University Hospital, GhentCompletedPrimary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of LarynxBelgium
-
University Hospital, GhentCompletedPrimary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of LarynxBelgium
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca; European Organisation for Research and Treatment of Cancer - EORTC and other collaboratorsActive, not recruitingOral Cavity Squamous Cell CarcinomaBelgium
-
Cliniques universitaires Saint-Luc- Université...RecruitingOropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Larynx Squamous Cell CarcinomaBelgium
-
University Hospital, AntwerpAgentschap voor Innovatie door Wetenschap en TechnologieCompletedLocally Advanced Squamous Cell Carcinoma of the Head and Neck RegionBelgium, Netherlands
-
Jules Bordet InstituteInnate PharmaWithdrawnAdenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the EsophagusBelgium
-
Universitair Ziekenhuis BrusselRecruiting
-
European Organisation for Research and Treatment...Boehringer IngelheimCompletedCarcinoma, Squamous Cell of Head and NeckBelgium, Italy
-
Centre Hospitalier Universitaire Dinant Godinne...Not yet recruitingHead and Neck Squamous Cell Carcinoma | Tumor GrowthBelgium
-
Cliniques universitaires Saint-Luc- Université...RecruitingSquamous Cell Carcinoma of the Head and NeckBelgium
-
Universitaire Ziekenhuizen KU LeuvenFlemish League Against CancerTerminatedHead and Neck CancerBelgium
-
Cliniques universitaires Saint-Luc- Université...TerminatedSquamous Cell Carcinoma of the Head and NeckBelgium
-
Cliniques universitaires Saint-Luc- Université...RecruitingSquamous Cell Carcinoma of the Head and NeckBelgium
-
Cliniques universitaires Saint-Luc- Université...University Hospital, Rouen; University Hospital, Montpellier; Central Hospital... and other collaboratorsUnknownAssessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma (pet)Head and Neck Squamous Cell CarcinomaBelgium
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Genentech, Inc.Completed
-
Cliniques universitaires Saint-Luc- Université...CompletedSurgery | Head and Neck Squamous Cell Carcinoma | Growth FactorBelgium
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Stichting tegen KankerRecruitingSquamous Cell Carcinoma of Head and NeckBelgium
-
Jules Bordet InstituteActive, not recruitingHead and Neck Squamous Cell CarcinomaBelgium
-
Symphogen A/SCompletedCarcinoma, Squamous Cell of Head and NeckBelgium, France, Germany
-
Cliniques universitaires Saint-Luc- Université...CompletedSquamous Cell Carcinoma of the Head and NeckBelgium, Luxembourg
-
InflaRx GmbHMerck Sharp & Dohme LLCActive, not recruitingSCC - Squamous Cell Carcinoma of SkinUnited States, Spain, Germany, Belgium, France
-
GenmabCompletedHead and Neck CancerUnited Kingdom, Belgium, Slovakia, Hungary
-
AstraZenecaMedImmune LLCActive, not recruitingAdvanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and NeckSpain, United States, Belgium, Germany, United Kingdom, Italy
-
Brugmann University HospitalCompletedHigh Grade Cervical Epithelial Neoplasia (CIN2+)Belgium
-
Incyte CorporationActive, not recruitingAdvanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Gastrointestinal (GI) MalignanciesUnited States, Netherlands, Spain, United Kingdom, Belgium, Austria
-
AmgenMerck Sharp & Dohme LLCCompletedCarcinoma of the Head and NeckUnited States, Canada, Switzerland, France, Spain, United Kingdom, Italy, Belgium, Austria, Australia, Greece
-
Shattuck Labs, Inc.Active, not recruitingMelanoma | Renal Cell Carcinoma | Hodgkin Lymphoma | Gastric Adenocarcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Diffuse Large B Cell Lymphoma | Urothelial Carcinoma | Gastroesophageal Junction Adenocarcinoma | Squamous Cell Carcinoma of the Skin | Squamous Cell Carcinoma... and other conditionsUnited States, Canada, Belgium, Spain
-
EMD SeronoCompletedSquamous Cell Carcinoma of the Head and Neck CancerCzech Republic, France, United Kingdom, Belgium, Hungary, United States, Poland, Slovakia
-
ALX Oncology Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Belgium, Spain, Australia
-
Incyte CorporationCompletedSquamous Cell Carcinoma of Anal CanalSpain, United Kingdom, United States, Germany, Belgium, France, Denmark, Italy, Norway
-
European Organisation for Research and Treatment...Merck KGaA, Darmstadt, GermanyRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaFrance, Belgium, Netherlands, Norway, United Kingdom, Ireland, Italy, Slovenia, Germany, Spain
-
AstraZenecaCompletedNeoplasms, Squamous CellUnited States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
-
Centre Hospitalier Universitaire Dinant Godinne...RecruitingSupraglottic Squamous Cell Carcinoma | Early Stage (T1-T2, N0-N1,M0)Belgium
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the Oropharynx | HPV16 PositiveNetherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
-
European Organisation for Research and Treatment...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckFrance, Spain, Belgium, Italy, United Kingdom
-
Glycotope GmbHCompletedCetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer (RESGEX)Carcinoma, Squamous Cell of Head and NeckBelgium, France, Germany, Italy, Poland, Romania, Spain
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the OropharynxUnited States, Israel, Belgium, Germany, Spain, United Kingdom, Italy, France, Czechia
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckCroatia, Sweden, United States, Czech Republic, Italy, Russian Federation, South Africa, Spain, United Kingdom, Estonia, Latvia, Lithuania, Norway, Canada, Netherlands, Argentina, Belgium, Greece, Thailand, India, Israel, Malaysia, ... and more
-
Catherine VanpachterbekeCompletedHigh-Grade Squamous Intraepithelial LesionsBelgium
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
Genentech, Inc.CompletedHead and Neck CancerUnited States, Germany, Spain, France, Australia, Hungary, Belgium, Bulgaria, United Kingdom, Italy, Romania
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingOropharyngeal Squamous Cell CarcinomaCanada, Spain, Belgium, Italy
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia